Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

PURPOSE: Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has demonstrated superiority of chemoembolization compared with embolization, and the role of chemotherapy remains unclear. This randomized trial compares the outcome of embolization...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Oncol
Main Authors: Brown, Karen T., Do, Richard K., Gonen, Mithat, Covey, Anne M., Getrajdman, George I., Sofocleous, Constantinos T., Jarnagin, William R., D’Angelica, Michael I., Allen, Peter J., Erinjeri, Joseph P., Brody, Lynn A., O’Neill, Gerald P., Johnson, Kristian N., Garcia, Alessandra R., Beattie, Christopher, Zhao, Binsheng, Solomon, Stephen B., Schwartz, Lawrence H., DeMatteo, Ronald, Abou-Alfa, Ghassan K.
格式: Artigo
語言:Inglês
出版: American Society of Clinical Oncology 2016
主題:
ORIGINAL REPORTS
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966514/
https://ncbi.nlm.nih.gov/pubmed/26834067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.64.0821
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍